Patent intelligence · US
US 12023359
Phospholipid compositions for delivery of therapeutic compounds
Phospholipid compositions for delivery of therapeutic compounds
Patent details — US 12023359
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 2, 2024
- Expiration
- Jun 27, 2044
- Applicant
- Aker BioMarine Human Ingredients AS
- Claims
- 18
- CPC classes
- A61K, A61K31/12, A61K31/122, A61K31/202
Quick answer
US 12023359 (Phospholipid compositions for delivery of therapeutic compounds) is held by Aker BioMarine Human Ingredients AS. Status: granted. Granted Jul 2, 2024. Expires Jun 27, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aker BioMarine Human Ingredients AS
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K31/12, A61K31/122, A61K31/202, A61K31/232, A61K31/352
More from Aker BioMarine Human Ingredients AS
Related pharmaceutical patents in our USPTO index.
-
US 12427171
Krill oil composition enriched in LPC-DHA and LPC-EPA
granted -
US 12331293
Bispecific antisense oligonucleotides for dystrophin exon skipping
granted -
US 12239692
Adeno-associated virus factor VIII vectors
granted -
US 12233106
C-type natriuretic peptide variants to treat skeletal dysplasia in children
granted -
US 12214015
Use of c-type natriuretic peptide variants to treat osteoarthritis
granted -
US 12194064
Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids
granted -
US 12188058
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 12076372
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted
Frequently asked questions
What is US patent 12023359?
US 12023359 (Phospholipid compositions for delivery of therapeutic compounds) is held by Aker BioMarine Human Ingredients AS. Status: granted. Granted Jul 2, 2024. Expires Jun 27, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12023359?
Aker BioMarine Human Ingredients AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 175 pharmaceutical patents for this assignee.
When does US 12023359 expire?
Our index shows an expiration date of Jun 27, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.